Breaking News

M Pharmaceutical USA Becomes Callitas Therapeutics

Reflects wide-ranging business objective of developing innovative technologies for weight management and female health

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

M Pharmaceutical, Inc. is changing the name of its wholly owned subsidiary M Pharmaceutical USA, to Callitas Therapeutics, Inc. Callitas is a clinical-stage company developing products for weight management and female health and wellness. The new name is intended to reflect its broader commitment to drive innovations to shape the future of healthcare. “Our new name, Callitas Therapeutics, reflects our wide-ranging business objective of developing and delivering innovative technolo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters